Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011)

The detection of multi-resistant bacterial pathogens, particularly those to carbapenemases, in leukemic and stem cell transplant patients forces the use of old or non-conventional agents as the only remaining treatment options. These include colistin/polymyxin B, tigecycline, fosfomycin and various...

Full description

Bibliographic Details

Published in:	Haematologica
Main Authors:	Diana Averbuch, Catherine Cordonnier, David M. Livermore, Małgorzata Mikulska, Christina Orasch, Claudio Viscoli, Inge C. Gyssens, Winfried V. Kern, Galina Klyasova, Oscar Marchetti, Dan Engelhard, Murat Akova
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2013-12-01
Online Access:	https://haematologica.org/article/view/6858